Hilltop Holdings’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-11,893
| Closed | -$874K | – | 877 |
|
2025
Q1 | $874K | Buy |
11,893
+938
| +9% | +$68.9K | 0.05% | 353 |
|
2024
Q4 | $718K | Buy |
10,955
+1,587
| +17% | +$104K | 0.05% | 401 |
|
2024
Q3 | $730K | Buy |
+9,368
| New | +$730K | 0.05% | 380 |
|
2020
Q4 | – | Sell |
-6,680
| Closed | -$366K | – | 490 |
|
2020
Q3 | $366K | Buy |
6,680
+2,102
| +46% | +$115K | 0.06% | 280 |
|
2020
Q2 | $243K | Buy |
4,578
+63
| +1% | +$3.34K | 0.04% | 331 |
|
2020
Q1 | $202K | Sell |
4,515
-3,907
| -46% | -$175K | 0.05% | 309 |
|
2019
Q4 | $420K | Sell |
8,422
-2,575
| -23% | -$128K | 0.08% | 238 |
|
2019
Q3 | $490K | Sell |
10,997
-172
| -2% | -$7.66K | 0.09% | 208 |
|
2019
Q2 | $460K | Sell |
11,169
-3,567
| -24% | -$147K | 0.1% | 209 |
|
2019
Q1 | $596K | Sell |
14,736
-3,461
| -19% | -$140K | 0.13% | 166 |
|
2018
Q4 | $691K | Sell |
18,197
-6,190
| -25% | -$235K | 0.17% | 128 |
|
2018
Q3 | $965K | Sell |
24,387
-10,938
| -31% | -$433K | 0.2% | 126 |
|
2018
Q2 | $1.24M | Sell |
35,325
-2,486
| -7% | -$87.3K | 0.26% | 95 |
|
2018
Q1 | $1.32M | Buy |
37,811
+625
| +2% | +$21.8K | 0.23% | 106 |
|
2017
Q4 | $1.29M | Buy |
37,186
+3,295
| +10% | +$114K | 0.29% | 98 |
|
2017
Q3 | $1.15M | Buy |
33,891
+6,512
| +24% | +$221K | 0.35% | 84 |
|
2017
Q2 | $933K | Buy |
27,379
+6,273
| +30% | +$214K | 0.27% | 115 |
|
2017
Q1 | $657K | Buy |
21,106
+5,880
| +39% | +$183K | 0.2% | 150 |
|
2016
Q4 | $416K | Buy |
15,226
+2,053
| +16% | +$56.1K | 0.13% | 209 |
|
2016
Q3 | $432K | Buy |
+13,173
| New | +$432K | 0.14% | 203 |
|
2014
Q3 | – | Sell |
-13,498
| Closed | -$501K | – | 199 |
|
2014
Q2 | $501K | Sell |
13,498
-13,912
| -51% | -$516K | 0.23% | 109 |
|
2014
Q1 | $889K | Buy |
27,410
+12,714
| +87% | +$412K | 0.44% | 68 |
|
2013
Q4 | $437K | Buy |
14,696
+6,146
| +72% | +$183K | 0.22% | 113 |
|
2013
Q3 | $222K | Buy |
+8,550
| New | +$222K | 0.13% | 181 |
|